Improving process safety during clinical trials for new cardiology drug
A global conglomerate in the healthcare industry, with ongoing clinical trials in 15+ countries, wanted to ensure process safety and real-time monitoring of the trials.
Request a free proposal to know more about pharmacovigilance.
Real time monitoring of new drug clinical trial to ensure process safety
The healthcare industry client wanted real time monitoring of clinical trials for its new cardiology drug, in order to maintain clinical safety, closely monitor the use of the product in clinical practice, and predict and prevent potential serious safety risks
Pharmacovigilance analytics and CRF generation for hybrid reporting
We used process analytics, monitoring of summary of product characteristics (SmPC) compliance, benefit risk analysis, and adverse events reporting for understanding of protocols adherence and regulatory compliance in all data collection and reporting; along with case report forms (CRFs) generation for use in both EDC and paper based, (i.e. hybrid) reporting.
Improved trial accountability, prevention of serious safety risks
Through the insights from pharmacovigilance analytics, the client improved the accountability for drug development clinical trials, ensured regulatory compliance through documentation, and was able to conclude the study meeting all the safety objectives.